Max Healthcare Institute Limited has informed the Exchange regarding Presentation on Earnings Update for the quarter ended June 30, 2025
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Max Healthcare reported Q1 FY26 gross revenue of ₹2,574 Cr, up 27% year-on-year, driven primarily by a 26% rise in occupied bed days. Network operating EBITDA grew 23% YoY to ₹613 Cr, but margins contracted to 24.9% from 25.8% YoY and 27.2% in the previous quarter, as newer units (Dwarka and Noida) are still ramping up at a 12.2% margin. Profit after tax rose 17% YoY to ₹345 Cr, while free cash from operations stood at ₹389 Cr. Bed occupancy was steady at 76% and international patient revenue grew 32% YoY to ₹208 Cr. The Board approved a lease for a ~130-bed hospital in Dehradun (to be commissioned by 2028), while Jaypee Healthcare signed a binding term sheet to divest its Chitta and Anoopshahr hospitals for ₹40 Cr to sharpen focus on super-specialty care. The new ~160-bed tower at Max Mohali has begun trial runs, and net debt rose to ₹1,755 Cr from ₹1,576 Cr, largely to fund expansion.
Strong top-line growth and steady occupancy are positives, but margin contraction and rising debt from capacity expansion could temper near-term investor sentiment. The divestment of non-core hospitals and addition of capacity in larger cities are aligned with long-term value creation and may be viewed favourably over time.